Market Research Reports

Clinical Trial Management System (CTMS) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2019

113pages
Published Date: 2014-04-11
 

Description


Clinical trial management system (CTMS) is a software solution for proper management, storage and analysis of drugs associated clinical data. CTMS is primarily employed to manage large amount of data involved in a clinical trial including planning, preparation and reporting. CTMS also provides data to a business intelligence system. Increasing R&D investment in pharmaceuticals, life science and clinical research industries, rising prevalence of diseases and increased clinical research outsourcing are key growth drivers for the CTMS market. In addition, integration of CTMS with a Hospital Information System (HIS) provides more accurate and time saving documentation over paper based information systems.

On the other hand, long approval time for clinical trials and difficulties related to recruiting and enrolling patients for clinical trials are some of the major concerns for the industry. Approval from Institutional Review Board (IRB), contract and budget negotiation and approval, availability of appropriate patient population and protocol design and legal review are major factors that delay a drug approval process. Similarly, increasing regulatory requirements in many countries has resulted in increased complexity for clinical trial protocols.

This report provides an in-depth analysis of estimation of the CTMS market for the period 2013-2019, considering 2013 as the base year for calculation. In addition, data pertaining to current market dynamics including market drivers, restraints, trends and recent developments has been provided in the report. The CTMS market is categorized on the basis of type of CTMS, end users, components, mode of delivery and geography. Based on mode of delivery, the CTMS market comprises on-premise CTMS, Web based CTMS and cloud based CTMS. The end user market comprises pharmaceuticals, clinical research organizations and healthcare providers.

In the geographical analysis, the report identifies and analyses market size and forecast of North America, Europe, Asia and Rest of the World (RoW). North America is further segmented into the U.S. Similarly, Europe is further segmented into Germany, France and Poland. Asia is further segmented into South Korea and China. Some of the major players in the CTMS market are Oracle Corporation, Bio-Optronics, MedNet Solutions, PAREXEL, Medidata Solutions, BioClinica and others. These key market players have been profiled on the basis of attributes such as company overview, recent developments, growth strategies, sustainability, and financial overview.

Table of Contents


Chapter 1 Preface 11
1.1 Report Description 11
1.2 Research Methodology 12
      1.2.1 Sources 12
               1.2.1.1 Secondary Research 12
               1.2.1.2 Primary Research 12
               1.2.1.3 Assumptions 13

Chapter 2 Executive Summary 14

Chapter 3 Market Overview 16

Chapter 4 Market Trends 25

Chapter 5 Porters Five Force Analysis 27

Chapter 6 Global Market Size and Forecast 29

Chapter 7 Segment Analysis by Delivery Mode 31
7.1 Cloud Based Clinical Trial Management System 31
7.2 Web Based Clinical Trial Management System 32
7.3 On-Premise Clinical Trial Management System 32

Chapter 8 Segment Analysis by End User 34
8.1 Pharmaceuticals 34
8.2 Clinical Research Organizations (CROs) 34
8.3 Healthcare Providers 35

Chapter 9 Segment Analysis by Type 37
9.1 Enterprise Based Clinical Trial Management System 37
9.2 Site Based Clinical Trial Management System 37

Chapter 10 Segment Analysis by Components 39
10.1 Software 39
10.2 Hardware 40
10.3 Services 40

Chapter 11 Regional Analysis 42
11.1 North America 42
        11.1.1 U.S. 50
11.2 Europe 53
        11.2.1 Germany 61
        11.2.2 France 65
        11.2.3 Poland 68
11.3 Asia 71
        11.3.1 South Korea 79
        11.3.2 China 82
11.4 Rest of the world 86

Chapter 12 Competitive Landscape 87

Chapter 13 Company Profiles 89
13.1 Oracle Corporation 89
        13.1.1 Overview 89
        13.1.2 Products & Segments 89
        13.1.3 Financial Performance 90
        13.1.4 Strategic Developments 90
13.2 Merge Healthcare Inc. 92
        13.2.1 Overview 92
        13.2.2 Products & Segments 92
        13.2.3 Financial Performance 93
        13.2.4 Strategic Developments 94
13.3 Medidata 95
        13.3.1 Overview 95
        13.3.2 Products & Segments 95
        13.3.3 Financial Performance 95
        13.3.4 Strategic Development 96
13.4 PAREXEL International Corporation 98
        13.4.1 Overview 98
        13.4.2 Products & Segments 98
        13.4.3 Financial Performance 99
        13.4.4 Strategic Developments 99
13.5 BioClinica 101
        13.5.1 Overview 101
        13.5.2 Products and Segments 101
        13.5.3 Financial Performance 102
        13.5.4 Strategic Developments 102
13.6 MedNet Solutions 104
        13.6.1 Overview 104
        13.6.2 Products & Segments 104
        13.6.3 Financial Performance 104
        13.6.4 Strategic Developments 104
13.7 Bio-Optronics 106
        13.7.1 Overview 106
        13.7.2 Products & Segments 106
        13.7.3 Financial Performance 106
        13.7.4 Strategic Developments 106
13.8 DSG 108
        13.8.1 Overview 108
        13.8.2 Products & Segments 108
        13.8.3 Financial Performance 108
        13.8.4 Strategic Developments 108
13.9 eClinForce 110
        13.9.1 Overview 110
        13.9.2 Products & Segments 110
        13.9.3 Financial Performance 110
13.10 Forte Research Systems 111
        13.10.1 Overview 111
        13.10.2 Products & Segments 111
        13.10.3 Financial Performance 111
        13.10.4 Strategic Developments 111

List of Figures 

FIG. 1 Applications of clinical trial management system 17
FIG. 2 Process of CTMS 18
FIG. 3 CTMS Market: Porters Five Force Analysis 27
FIG. 4 Global clinical trial management system market, by region 2013E (% share) 29
FIG. 5 Global clinical trial management system market, by mode of delivery 2013E (% share) 31
FIG. 6 Global clinical trial management system market, by end user 2013E (% share) 34
FIG. 7 Global clinical trial management system market, by type 2013E (% share) 37
FIG. 8 Global clinical trial management system market, by components 2013E (% share) 39
FIG. 9 The North American clinical trial management system market, by country 2013E (% share) 42
FIG. 10 The North American clinical trial management system market, by mode of delivery 2013E (% share) 44
FIG. 11 The North American clinical trial management system market, by end user 2013E (% share) 45
FIG. 12 The North American clinical trial management system market, by type 2013E (% share) 47
FIG. 13 The North American clinical trial management system market, by component 2013E (% share) 48
FIG. 14 The U.S. clinical trial management system market, by mode of delivery 2013E (% share) 50
FIG. 15 The U.S. clinical trial management system market, by end user 2013E (% share) 51
FIG. 16 The European clinical trial management system market, by country 2013E (% share) 54
FIG. 17 The European clinical trial management system market, by mode of delivery 2013E (% share) 55
FIG. 18 The European clinical trial management system market, by end user 2013E (% share) 57
FIG. 19 The European clinical trial management system market, by type 2013E (% share) 58
FIG. 20 The European clinical trial management system market, by component 2013E (% share) 60
FIG. 21 The German clinical trial management system market, by mode of delivery 2013E (% share) 62
FIG. 22 The German clinical trial management system market, by end user 2013E (% share) 63
FIG. 23 The French clinical trial management system market, by mode of delivery 2013E (% share) 65
FIG. 24 The French clinical trial management system market, by end user 2013E (% share) 66
FIG. 25 Poland clinical trial management system market, by mode of delivery 2013E (% share) 68
FIG. 26 Poland clinical trial management system market, by end user 2013E (% share) 69
FIG. 27 The Asian clinical trial management system market, by country 2013E (% share) 72
FIG. 28 The Asian clinical trial management system market, by mode of delivery 2013E (% share) 73
FIG. 29 The Asian clinical trial management system market, by end user 2013E(% share) 75
FIG. 30 The Asian clinical trial management system market, by type 2013E (% share) 76
FIG. 31 The Asian clinical trial management system market, by component 2013E (% share) 78
FIG. 32 The South Korean clinical trial management system market, by mode of delivery 2013E (% share) 80
FIG. 33 The South Korean clinical trial management system market, by end user 2013E (% share) 81
FIG. 34 The Chinese clinical trial management system market, by mode of delivery 2013E (% share) 83
FIG. 35 The Chinese clinical trial management system market, by end user 2013E (% share) 84
FIG. 36 Competitive landscape of the global CTMS market 87
FIG. 37 Oracle Corporation total revenue and net income 2011-2013 (USD Million) 90
FIG. 38 Merge Healthcare net sales and net income 2011-2013 (USD Million) 93
FIG. 39 Medidata total revenue and net income 2011-2013 (USD Million) 96
FIG. 40 PAREXEL total service revenue and net income 2011-2013 (USD Million) 99
FIG. 41 BioClinica total revenue and net income 2010-2012 (USD Million) 102

List of Tables

TABLE 1 Market Snapshot: CTMS market (2013 & 2019) 14
TABLE 2 Drivers for CTMS market: Impact analysis 18
TABLE 3 R&D investment in pharmaceutical industry, by country (USD million) in 2010 and 2011
TABLE 4 Globally rising prevalence of diabetics, by number of cases (million, 2010 and 2030) 20
TABLE 5 Restraints for CTMS market: Impact analysis 22
TABLE 6 Estimated average timelines for clinical trial approval in various countries 23
TABLE 7 Major collaborations and partnerships by CTMS companies (2011- February 2014) 25
TABLE 8 Some of the major mergers and acquisitions in CTMS market (2011-Februrary 2014) 26
TABLE 9 Global clinical trial management system market size, by region 2009-2012 (USD million) 29
TABLE 10 Global clinical trial management system market size, by region 2013-2019 (USD million) 30
TABLE 11 Global clinical trial management system market size, by mode of delivery 2009-2012 (USD million) 32
TABLE 12 Global clinical trial management system market size, by mode of delivery 2013-2019 (USD million) 33
TABLE 13 Global clinical trial management system market size, by end user 2009-2012 (USD million) 35
TABLE 14 Global clinical trial management system market size, by end user 2013-2019 (USD million) 36
TABLE 15 Global clinical trial management system market size, by type 2009-2012 (USD million) 38
TABLE 16 Global clinical trial management system market size, by type 2013-2019 (USD million) 38
TABLE 17 Global clinical trial management system market size, by component 2009-2012 (USD million) 40
TABLE 18 Global clinical trial management system market size, by component 2013-2019 (USD million) 40
TABLE 19 The North American clinical trial management market size, by segment 2009-2012 (USD million) 43
TABLE 20 The North American clinical trial management market size, by segment 2013-2019 (USD million) 43
TABLE 21 The North American clinical trial management system market size, by mode of delivery 2009-2012 (USD million) 44
TABLE 22 The North American clinical trial management system market size, by mode of delivery 2013-2019 (USD million) 45
TABLE 23 The North American clinical trial management system market size, by end user 2009-2012 (USD million) 46
TABLE 24 The North American clinical trial management system market size, by end user 2013-2019 (USD million) 46
TABLE 25 The North American clinical trial management system market size, by type 2009-2012 (USD million) 47
TABLE 26 The North American clinical trial management system market size, by type 2013-2019 (USD million) 48
TABLE 27 The North American clinical trial management system market size, by component 2009-2012 (USD million) 49
TABLE 28 The North American clinical trial management system market size, by component 2013-2019 (USD million) 49
TABLE 29 The U.S. clinical trial management system market size, by mode of delivery 2009-2012 (USD million) 50
TABLE 30 The U.S. clinical trial management system market size, by mode of delivery 2013-2019 (USD million) 51
TABLE 31 The U.S. clinical trial management system market size, by end user 2009-2012 (USD million) 52
TABLE 32 The U.S. clinical trial management system market size, by end user 2013-2019 (USD million) 52
TABLE 33 The European clinical trial management market size, by segment 2009-2012 (USD million) 54
TABLE 34 The European clinical trial management market size, by segment 2013-2019 (USD million) 55
TABLE 35 The European clinical trial management system market size, by mode of delivery 2009-2012 (USD million) 56
TABLE 36 The European clinical trial management system market size, by mode of delivery 2013-2019 (USD million) 56
TABLE 37 The European clinical trial management system market size, by end user 2009-2012 (USD million) 57
TABLE 38 The European clinical trial management system market size, by end user 2013-2019 (USD million) 58
TABLE 39 The European clinical trial management system market size, by type 2009-2012 (USD million) 59
TABLE 40 The European clinical trial management system market size, by type 2013-2019 (USD million) 59
TABLE 41 The European clinical trial management system market size, by component 2009-2012 (USD million) 60
TABLE 42 The European clinical trial management system market size, by component 2013-2019 (USD million) 61
TABLE 43 The German clinical trial management system market size, by mode of delivery 2009-2012 (USD million) 62
TABLE 44 The German clinical trial management system market size, by mode of delivery 2013-2019 (USD million) 63
TABLE 45 The German clinical trial management system market size, by end user 2009-2012 (USD million) 64
TABLE 46 The German clinical trial management system market size, by end user 2013-2019 (USD million) 64
TABLE 47 The French clinical trial management system market size, by mode of delivery 2009-2012 (USD million) 65
TABLE 48 The French clinical trial management system market size, by mode of delivery 2013-2019 (USD million) 65
TABLE 49 The French clinical trial management system market size, by end user 2009-2012 (USD million) 67
TABLE 50 The French clinical trial management system market size, by end user 2013-2019 (USD million) 67
TABLE 51 Poland clinical trial management system market size, by mode of delivery 2009-2012 (USD million) 68
TABLE 52 Poland clinical trial management system market size, by mode of delivery 2013-2019 (USD million) 69
TABLE 53 Poland clinical trial management system market size, by end user 2009-2012 (USD million) 70
TABLE 54 Poland clinical trial management system market size, by end user 2013-2019 (USD million) 70
TABLE 55 The Asian clinical trial management market size, by segment 2009-2012 (USD million) 72
TABLE 56 The Asian clinical trial management market size, by segment 2013-2019 (USD million) 73
TABLE 57 The Asian clinical trial management system market size, by mode of delivery 2009-2012 (USD million) 74
TABLE 58 The Asian clinical trial management system market size, by mode of delivery 2013-2019 (USD million) 74
TABLE 59 The Asian clinical trial management system market size, by end user 2009-2012 (USD million) 75
TABLE 60 The Asian clinical trial management system market size, by end user 2013-2019 (USD million) 76
TABLE 61 The Asian clinical trial management system market size, by type 2009-2012 (USD million) 77
TABLE 62 The Asian clinical trial management system market size, by type 2013-2019 (USD million) 77
TABLE 63 The Asian clinical trial management system market size, by component 2009-2012 (USD million) 78
TABLE 64 The Asian clinical trial management system market size, by component 2013-2019 (USD million) 79
TABLE 65 The South Korean clinical trial management system market size, by mode of delivery 2009-2012 (USD million) 80
TABLE 66 The South Korean clinical trial management system market size, by mode of delivery 2013-2019 (USD million) 81
TABLE 67 The South Korean clinical trial management system market size, by end user 2009-2012 (USD million) 82
TABLE 68 The South Korean clinical trial management system market size, by end user 2013-2019 (USD million) 82
TABLE 69 The Chinese clinical trial management system market size, by mode of delivery 2009-2012 (USD million) 83
TABLE 70 The Chinese clinical trial management system market size, by mode of delivery 2013-2019 (USD million) 84
TABLE 71 The Chinese clinical trial management system market size, by end user 2009-2012 (USD million) 85
TABLE 72 The Chinese clinical trial management system market size, by end user 2013-2019 (USD million) 85

Enquiry Before Buying


Free Market Analysis


Clinical trial management system (CTMS) is a software solution for proper management, storage and analysis of drugs associated clinical data. Globally, the CTMS market is witnessing significant growth due to increasing R&D investment in pharmaceutical, life science and clinical research industries.It empowers organizations and research centers to enhance productivity and effectiveness of clinical trials by advancing and managing clinical trials. Integration of CTMS with HIS provides more accurate and time saving documentation, and it is also one of the major driving factors for the growth of the CTMS market. 

Additionally, increasing prevalence of diseases is supporting clinical trials in different regions, and increased clinical research outsourcing is playing a major role in the growth of the CTMS market. Presence of various end users such as pharmaceuticals, clinical research organizations (CRO) and healthcare providers has increased the acceptance of CTMS. The CTMS market was estimated to be USD 844 million in 2013. It is likely to grow at a CAGR of 14% during 2013 to 2019 to reach USD 1,848.5 million in 2019.

North America has the largest market share in the global CTMS market. Web based CTMS is the largest mode of delivery and pharmaceutical industry is the largest end user of CTMS. In terms of growth, Asia is the fastest growing region, cloud based CTMS is the fastest growing mode of delivery and CRO’s are the fastest growing end users of CTMS. 
North American market for CTMS was estimated at USD 514.4 million in 2013 and is expected to reach USD 1,107.5 million in 2019, growing at a CAGR of 13.6% from 2013 to 2019. Software segment was estimated at USD 585 million in 2013 and is expected to reach USD 1,274.2 million in 2019, growing at a CAGR of 13.9% from 2013 to 2019. 

Oracle Corporation and PAREXEL are leading players in the market. Other major players of clinical trial management system market include BioClinica, MedNet Solutions, eClinforce, Bio-Optronics, Forte Research and DSG.

Global clinical trial management system market size, by region 2013-2019 (USD million)
 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research